Reposted by B. Arman Aksoy
Among many things, in this episode we discuss:
- Obsidian's lead program, OBX-115, a modified TIL cell therapy
- The critical role of TCR sequencing in profiling infusion products, tracking clonotypes, and identifying biomarkers for therapy response.
Listen/View here:
youtu.be/J41q0fUqeVo?...
youtu.be
The Repertoire Room: Episode 3 - Arman Aksoy (Obsidian Therapeutics)
YouTube video by ImmuneWatch